Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 1, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

Practical Techniques: Photopatch Testing.

Brandon L Adler1, Jonathan Zippin2, Vincent DeLeo1

  • 1From the *Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Dermatitis : Contact, Atopic, Occupational, Drug
|June 30, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Acrylate Copolymers/Crosspolymers in Sunscreens: Minimally Allergenic, Without Evidence of Need for Avoidance by (Meth)Acrylate-Sensitized Individuals.

Contact dermatitis·2026
Same author

Long-term disability outcomes in Hansen's disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy.

PLoS neglected tropical diseases·2026
Same author

Response to Pak et al., "Regulatory Gaps in Sunscreen Approval: A Comparison of U.S. and Korean UV Filters." Sunscreen Regulatory Update: Approval of Bemotrizinol by the US FDA.

Journal of the American Academy of Dermatology·2026
Same author

<i>Letter:</i> Syncope and Contact Urticaria Following Patch Testing to Natural Product Allergens.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Occupational contact dermatitis in North American health care workers: Trends and triggers (2005-2022).

Journal of the American Academy of Dermatology·2026
Same journal

<i>Letter:</i> Anogenital Dermatitis Rarely Occurs in Isolation: Disease Distribution and Delays in Patch Testing.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Digital Image Superimposition for Identifying Delayed Patch Test Reactions: A Clinical Pearl.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Analysis of Sulfite Concentrations in Common Beverages Consumed in the United States.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

<i>Letter:</i> Nickel Sensitization After Patent Foramen Ovale Closure.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

<i>Letter:</i> Reactions to Niacinamide, Our Experience from 2022 to 2025.

Dermatitis : contact, atopic, occupational, drug·2026
See all related articles

Photopatch testing (PPT) is the gold standard for diagnosing photoallergic contact dermatitis (PACD). This guide offers practical approaches to improve PPT performance in clinical settings for better patient outcomes.

Area of Science:

  • Dermatology
  • Allergy and Immunology
  • Photobiology

Background:

  • Photoallergic contact dermatitis (PACD) is a type IV hypersensitivity reaction.
  • Common photoallergens include sunscreen filters (US) and topical NSAIDs (Europe).
  • Despite being the gold standard, photopatch testing (PPT) is underutilized clinically.

Purpose of the Study:

  • To provide practical, expert-opinion-based recommendations for photopatch testing (PPT).
  • To address limiting factors hindering PPT performance in clinical practice.
  • To guide patient selection and optimize the testing procedure for diagnosing PACD.

Main Methods:

  • Expert consensus and clinical experience on photopatch testing (PPT).
  • Review of current practices and challenges in diagnosing PACD.

More Related Videos

Minimal Erythema Dose (MED) Testing
06:24

Minimal Erythema Dose (MED) Testing

Published on: May 28, 2013

Application of Automated Image-guided Patch Clamp for the Study of Neurons in Brain Slices
09:05

Application of Automated Image-guided Patch Clamp for the Study of Neurons in Brain Slices

Published on: July 31, 2017

Related Experiment Videos

Last Updated: Jul 1, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

Minimal Erythema Dose (MED) Testing
06:24

Minimal Erythema Dose (MED) Testing

Published on: May 28, 2013

Application of Automated Image-guided Patch Clamp for the Study of Neurons in Brain Slices
09:05

Application of Automated Image-guided Patch Clamp for the Study of Neurons in Brain Slices

Published on: July 31, 2017

  • Development of straightforward recommendations for PPT implementation.

    • Main Results:

    • Identification of key photoallergens in different geographic regions.
    • Analysis of factors contributing to the underperformance of PPT.
    • Formulation of practical guidelines for patient selection and testing.

    Conclusions:

    • Photopatch testing (PPT) is crucial for diagnosing PACD.
    • Standardized approaches can enhance PPT utilization and accuracy.
    • Improved PPT practices will benefit photosensitive patients.